Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for prevention of oxaliplatin-induced peripheral neuropathy
IRCT20100127003210N15Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of duloxetine in colorectal cancer (CRC) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Neuropathy, Quality of life and 1 more. Started Feb 2017; status: completed.
02
Drugs
duloxetine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on IRCT20100127003210N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003210N15.